Results 251 to 260 of about 14,611,928 (419)

Efficacy of a Tumor Necrosis Factor Inhibitor in Chronic Low‐Back Pain With Modic Type 1 Changes: A Randomized Controlled Trial

Arthritis &Rheumatology, EarlyView.
Efficacy of a Tumor necrosis inhibitor in chronic low‐back pain with Modic type 1 changes: The BackToBasic study, A randomized controlled trial. Objective The efficacy of tumor necrosis factor inhibitors for treating chronic low‐back pain with Modic changes is uncertain.
Elisabeth Gjefsen, Lars C. Bråten, Erica Ponzi, Magnhild H. Dagestad, Gunn H. Marchand, Thomas Kadar, Gunnstein Bakland, Anne J. Haugen, Fredrik Granviken, Tonje W. Flørenes, Nils Vetti, Lars Grøvle, Aksel T. Nilsen, Astrid Lunestad, Thor E. Holmgard, Morten Valberg, Nils Bolstad, Ansgar Espeland, Jens I. Brox, Guro L. Goll, Kjersti Storheim, John‐Anker Zwart   +21 more
wiley   +1 more source

Lymphatic metastasis in non‐small cell lung cancer: recent discoveries and novel therapeutic targets

, 2022
Cancer Communications, Volume 42, Issue 12, Page 1403-1406, December 2022.
Xiayao Diao, Chao Guo, Shanqing Li
wiley   +1 more source

The mortality for the implantable cardiac defibrillator in nonischemic cardiomyopathy: An updated systematic review and meta‐analysis

Clinical Cardiology, Volume 45, Issue 12, Page 1163-1170, December 2022., 2022
Abstract The implantable cardiac defibrillator (ICD) is common for the management of nonischemic cardiomyopathy (NICM). Mortality is a crucial issue for patients with NICM. We can understand the mortality events of ICD versus medicine treatment via a systemic review and meta‐analysis of randomized clinical trials.
Wenfeng He, Cheng Xue, Jiankang Zheng, Zhuang Shuai   +3 more
wiley   +1 more source

Re-evaluation of Significance and the Implications of Placebo Effect in Antidepressant Therapy

Frontiers in Psychiatry, 2019
Marko Curkovic, Andro Kosec, Aleksandar Savic, Aleksandar Savic   +3 more
doaj   +1 more source

Compression-induced improvements in post-exercise recovery are associated with enhanced blood flow, and are not due to the placebo effect. [PDF]

Sci Rep, 2022
O'Riordan SF, Bishop DJ, Halson SL, Broatch JR.   +3 more
europepmc   +1 more source

Clinical effect of an anti-anxiety drug on vertigo. Double-blind comparison of etizolam and placebo.

, 1990
Hitoshi Ogino, Izumi Koizuka, Noriaki Takeda, Toru Matsunaga   +3 more
openalex   +2 more sources

Effect of high dose growth hormone with glutamine and no change in diet on intestinal absorption in short bowel patients: a randomised, double blind, crossover, placebo controlled study [PDF]

, 2000
J Szkudlarek
openalex   +1 more source

Outcome of Patients With Lupus Nephritis Treated With an Anti‐CD40 Monoclonal Antibody According to Kidney Biopsy Features

Arthritis &Rheumatology, EarlyView.
Objective A phase 2 trial tested different doses of the anti‐CD40 monoclonal antibody BI 655064 as an add‐on therapy to the standard of care in patients with class III or IV lupus nephritis (LN) with active disease. A post hoc analysis showed a potential benefit of the higher tested doses (180 and 240 mg) versus a low dose (120 mg) or placebo.
Martina Uzzo, Helmut Schumacher, Juergen Steffgen, Simone Deutschel, David Jayne, Ingeborg Bajema   +5 more
wiley   +1 more source

Efficacy and safety of rivaroxaban versus placebo after lower extremity bypass surgery: A post hoc analysis of a “CASPAR like” outcome from VOYAGER PAD

Clinical Cardiology, Volume 45, Issue 12, Page 1143-1146, December 2022., 2022
Abstract Background The Clopidogrel and Acetylsalicylic Acid in Bypass Surgery for Peripheral Arterial Disease (CASPAR) trial is the only large, double‐blind, placebo‐controlled trial of dual antiplatelet therapy (DAPT) versus aspirin in patients with peripheral artery disease (PAD) after lower extremity revascularization (LER).
Marc P. Bonaca, Michael Szarek, E. Sebastian Debus, Mark R. Nehler, Manesh R. Patel, Sonia S. Anand, Eva Muehlhofer, Scott D. Berkowitz, Lloyd P. Haskell, Rupert M. Bauersachs   +9 more
wiley   +1 more source

Real effect vs placebo effect. [PDF]

J Clin Sleep Med, 2021
Hunasikatti M.
europepmc   +1 more source